UBS lowered the firm’s price target on Honeywell to $175 from $180 and keeps a Sell rating on the shares. The firm continues to think “the bar is being set too high” and that short cycle risk is “not over yet.” Honeywell has generated “worst in class organic growth” over 2020-2023, added the analyst, who is now applying a lower multiple for lower growth and “still” modeling EPS below consensus.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See the top stocks recommended by analysts >>
Read More on HON:
- Triumph Group, Honeywell Aerospace sign long term agreement
- Honeywell price target lowered to $231 from $242 at Citi
- Honeywell price target lowered to $212 from $229 at Barclays
- Honeywell’s (NASDAQ:HON) Mixed-Bag Earnings Means Little to Investors
- Honeywell says Aerospace ‘continues to be a bright spot’